GSK Investigational Site
Levanger 7600
0 studies enrolling now · 4 studies all time
What they study most
Arthritis, Rheumatoid, Pulmonary Disease, Chronic Obstructive
Studies at this site
- A Study Comparing the Efficacy, Safety and Tolerability of Fixed Dose Combination (FDC) of FF/UMEC/VI With the FDC of FF/VI and UMEC/VI; Administered Once-daily Via a Dry Powder Inhaler (DPI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD) — Completed
- Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-centre, Dose Ranging Study to Evaluate the Efficacy and Safety of Losmapimod Tablets Administered Twice Daily Compared With Placebo for 24 Weeks in Adult Subjects With Chronic Obstructive Pulmonary Disease (COPD). — Completed
- Chronic Obstructive Pulmonary Disease (COPD) Post-hospitalization Study — Completed
- COX-2 Inhibitor Study In Patients With Rheumatoid Arthritis — Completed